Stay updated on Tenecteplase in Stroke Patients 4.5-24 Hours Clinical Trial
Sign up to get notified when there's something new on the Tenecteplase in Stroke Patients 4.5-24 Hours Clinical Trial page.

Latest updates to the Tenecteplase in Stroke Patients 4.5-24 Hours Clinical Trial page
- CheckyesterdayChange DetectedThe footer’s displayed ClinicalTrials.gov revision changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe TIMELESS study page now shows a 403 Forbidden error, replacing the usual study details with a generic error screen. Access to the study record and its documents appears blocked, indicating an access issue rather than a content update.SummaryDifference18%

- Check43 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6. This indicates a new version of the page in the site's revision history.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page now shows revision v3.6.5, reflecting a site update. The study content remains unchanged.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a new build of the page content, but does not modify the study information presented.SummaryDifference0.0%

- Check101 days agoChange DetectedThe revision tag was updated from v3.6.2 to v3.6.3, reflecting a metadata update to the study record rather than substantive alterations to the trial details.SummaryDifference0.0%

Stay in the know with updates to Tenecteplase in Stroke Patients 4.5-24 Hours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tenecteplase in Stroke Patients 4.5-24 Hours Clinical Trial page.